Skip to content
About
Board of Directors
Acer Management
Key Strategic Consultants
Scientific Advisory Board
Careers
Product
Pipeline
OLPRUVA™ Investigational Lifecycle Opportunities
EDSIVO™ for vEDS
ACER-801 for VMS
ACER-801 for ASD & PTSD
ACER-801 for Prostate Cancer
Patients & Physicians
Patient Advocacy
Publications
Maple Syrup Urine Disease (MSUD)
Vascular Ehlers-Danlos Syndrome (vEDS)
Vasomotor Symptoms (VMS)
Acute Stress Disorder (ASD) & Post-Traumatic Stress Disorder (PTSD)
Prostate Cancer
Expanded Access
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Analyst Coverage
Stock Information
Corporate Governance
Investor FAQs
Contact Us
About
Pipeline
Investor Relations
Publications
Contact Us
Investor FAQs
Analyst Coverage
Corporate Governance
Stock Information
Events & Presentations
About
Pipeline
Investor Relations
Publications
Contact Us
0001157523-06-000306
SEC Reports
QUICK
NAV
MENU
MENU
About
Acer Management
Board of Directors
Key Strategic Consultants
Scientific Advisory Board
Product
Pipeline
Careers
OLPRUVA™ Investigational Lifecycle Opportunities
EDSIVO™ for vEDS
ACER-801 for VMS
ACER-801 for Acute Stress Disorder (ASD) & Post-traumatic Stress Disorder (PTSD)
ACER-801 for Prostate Cancer
Patients & Physicians
Patient Advocacy
Publications
Maple Syrup Urine Disease (MSUD)
Vascular Ehlers-Danlos Syndrome (vEDS)
Vasomotor Symptoms (VMS)
Acute Stress Disorder and Post-Traumatic Stress Disorder
Prostate Cancer
Expanded Access
Investor Relations
Press Releases
Events & Presentations
SEC Filings
Analyst Coverage
Stock Information
Corporate Governance
Investor FAQs
Contact Us
